Answers are grounded in this paper and cite their sources.
The metabolism of drugs takes place for the most part in the liver. Next to the liver, however, microbiota in the gut also play an active role in the metabolism of drugs, either in generating active compounds or deactivating the drug. In vivo, the gastrointestinal tract is populated by a complex and highly individual microbiota. Gut organoids are powerful ex vivo tools for studying drug metabolism. Organoids also allow for studying the role of microbiota in drug metabolism. The technical challenges in co-culturing eukaryotic organoids with prokaryotic bacteria are considerable and have only partly been overcome. Next steps will include mimicking the complex composition of the gut microbiome and distinguishing between host and microbial metabolites. This manuscript provides a state-of-the-art overview of current concepts and of the most promising avenues for future research and applications in drug development.
No takes yet. Share an insight, caveat, or question.
Herega et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: